The chairman of Egetis Therapeutics AB (publ) has established a Nomination Committee according to the process approved by the 2021 Annual General Meeting. The 2022 AGM is planned to be held on May 10, 2022. The Nomination Committee is composed of members appointed by the three shareholders in terms of voting rights, that have accepted the invitation to join the committee. The following members have been appointed by the subsequent shareholders: Cidro F?rvaltning AB: Peter Lindell; Avla Holding AB: Kennet Rooth; Fj?rde AP-fonden: Jannis Kitsakis. The Nomination Committee has elected Kennet Rooth as chairman. Thomas L?nngren, Chairman of the Board of Directors, will co-opt to the Nomination Committee.